Search Results

You are looking at 1 - 5 of 5 items for :

  • Gut microbiome special collection x
  • Refine by access: All content x
Clear All
Nicole G Barra Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Nicole G Barra in
Google Scholar
PubMed
Close
,
Fernando F Anhê Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Fernando F Anhê in
Google Scholar
PubMed
Close
,
Joseph F Cavallari Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Joseph F Cavallari in
Google Scholar
PubMed
Close
,
Anita M Singh Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Anita M Singh in
Google Scholar
PubMed
Close
,
Darryl Y Chan Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Darryl Y Chan in
Google Scholar
PubMed
Close
, and
Jonathan D Schertzer Department of Biochemistry and Biomedical Sciences, Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Jonathan D Schertzer in
Google Scholar
PubMed
Close

extraction from food ( Bäckhed et al. 2007 ). The gut microbiota can also influence blood glucose. Lower bacterial diversity correlates with insulin resistance and higher adiposity (reviewed in Zhu & Goodarzi 2020 ). Type 2 diabetes (T2D) is associated

Free access
Marion Régnier UCLouvain, Université Catholique de Louvain, WELBIO – Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Brussels, Belgium

Search for other papers by Marion Régnier in
Google Scholar
PubMed
Close
,
Matthias Van Hul UCLouvain, Université Catholique de Louvain, WELBIO – Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Brussels, Belgium

Search for other papers by Matthias Van Hul in
Google Scholar
PubMed
Close
,
Claude Knauf Université Paul Sabatier, Toulouse III, INSERM U1220, Institut de Recherche en Santé Digestive (IRSD), CHU Purpan, Place du Docteur Baylac, Toulouse Cedex 3, France
European Associated Laboratory (EAL) ‘NeuroMicrobiota’, Brussels/Toulouse, Belgium

Search for other papers by Claude Knauf in
Google Scholar
PubMed
Close
, and
Patrice D Cani UCLouvain, Université Catholique de Louvain, WELBIO – Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Brussels, Belgium
European Associated Laboratory (EAL) ‘NeuroMicrobiota’, Brussels/Toulouse, Belgium

Search for other papers by Patrice D Cani in
Google Scholar
PubMed
Close

Introduction Obesity is linked with many cardiometabolic risk factors, such as insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). Although lowering body weight is effective for alleviating several of these

Free access
Erica Yeo Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada
Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada

Search for other papers by Erica Yeo in
Google Scholar
PubMed
Close
,
Patricia L Brubaker Department of Physiology, University of Toronto, Toronto, ON, Canada
Department of Medicine, University of Toronto, Toronto, ON, Canada

Search for other papers by Patricia L Brubaker in
Google Scholar
PubMed
Close
, and
Deborah M Sloboda Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada
Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada
Department of Obstetrics, Gynecology and Pediatrics, McMaster University, Hamilton, ON, Canada

Search for other papers by Deborah M Sloboda in
Google Scholar
PubMed
Close

. 1 ). These adaptations, however, must be finely tuned, as excessive insulin resistance and/or failure to increase β-cell mass can result in pregnancy complications including gestational diabetes mellitus (GDM, diabetes first diagnosed in pregnancy

Open access
Julie Rodriguez Metabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de Louvain, Brussels, Belgium

Search for other papers by Julie Rodriguez in
Google Scholar
PubMed
Close
and
Nathalie M Delzenne Metabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de Louvain, Brussels, Belgium

Search for other papers by Nathalie M Delzenne in
Google Scholar
PubMed
Close

Glucose homeostasis disruptions are associated with changes in the gut microbiota in diabetes and obesity Obesity is often associated with a range of metabolic alterations including insulin resistance, type 2 diabetes, dyslipidemia

Free access
Fabio Arturo Iannotti Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Campania, Italy

Search for other papers by Fabio Arturo Iannotti in
Google Scholar
PubMed
Close
and
Vincenzo Di Marzo Director, Joint International Research Unit for the Chemical and Biomolecular Study of the Microbiome in Metabolic Health and Nutrition (JIRU-MicroMeNu) between the Consiglio Nazionale delle Ricerche (CNR, Institute of Biomolecular Chemistry) and Université Laval, Naples, Campania, Italy
Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Department of Medicine, Faculty of Medicine and School of Nutrition, Faculty of Agricultural and Food Sciences, CRIUCPQ, INAF and Centre NUTRISS, Université Laval, Québec City, Canada

Search for other papers by Vincenzo Di Marzo in
Google Scholar
PubMed
Close

, such as type 2 diabetes (T2D), hepatosteatosis and atherosclerosis, differ from that of metabolically healthy subjects ( Allin et al. 2018 , Cani 2019 , Zhong et al. 2020 ). However, the nature and extent of such differences may vary considerably

Free access